Infect Chemother.  2013 Jun;45(2):217-224. 10.3947/ic.2013.45.2.217.

Perceptions of Tetanus-diphteria-acellular pertussis (Tdap) Vaccination among Korean Women of Childbearing Age

• Kim IS
• Seo YB
• Hong KW
• Noh JY
• Choi WS
• Song JY
• Cho GJ
• Oh MJ
• Kim HJ
• Hong SC
• Sohn JW
• Kim WJ
• Cheong HJ

• KMID: 2285003
• DOI: http://doi.org/10.3947/ic.2013.45.2.217

Abstract

BACKGROUND
The number of cases of pertussis reported has increased gradually in the last decade. Pertussis vaccination is the most effective strategy for the prevention of infection. Despite the fact that young infants are at the highest risk for pertussis, the rate of tetanus-diphtheria-acellular pertussis (Tdap) vaccination is presumed to be very low among women of childbearing age in Korea. The purpose of this study was to investigate the perceptions of women of childbearing age regarding Tdap vaccination in Korea.
MATERIALS AND METHODS
Women of childbearing age, who visited the Department of Obstetrics and Gynecology at 3 University hospitals in the Seoul and Gyeonggi-do provinces of Korea, were surveyed. Individual questionnaires were administered from April to May 2012. Demographic data, Tdap vaccination history, general knowledge about pertussis, and information on factors associated with decision on vaccination were collected.
RESULTS
Of the 500 reproductive-age women enrolled, only 4 (0.8%) had received the Tdap. The most common reason for non-vaccination was the lack of awareness of pertussis and information about the Tdap. Totally, 171 (34.2%) responded that they would receive a Tdap vaccination in the future. By multivariate analysis, general confidence in the effectiveness of the vaccine (odds ratio [OR] = 1.88, 95% confidence interval [CI] 1.17 to 3.01) was indicated as an important factor for deciding whether to receive the Tdap vaccine (P < 0.01).
CONCLUSIONS
The coverage of Tdap vaccination of women of childbearing age, including pregnant women, is very low because of the lack of awareness of pertussis and the Tdap. Education of women of childbearing age about pertussis is very important to increase Tdap vaccination rates among these women, particularly during the perinatal period.

Keyword

Pertussis; Vaccination; Tdap; Childbearing age; Perception

MeSH Terms

Female
Gynecology
Hospitals, University
Humans
Infant
Korea
Multivariate Analysis
Obstetrics
Pregnant Women
Vaccination
Whooping Cough
Surveys and Questionnaires

Reference

1. Centers for Disease Control and Prevention (CDC). Pertussis--United States, 2001-2003. MMWR Morb Mortal Wkly Rep. 2005. 54:1283–1286.

2. Tsuji Y. Current trend and importance of prevention on pertussis. Nihon Rinsho. 2009. 67:2207–2212.

3. Campbell H, Amirthalingam G, Andrews N, Fry NK, George RC, Harrison TG, Miller E. Accelerating control of pertussis in England and Wales. Emerg Infect Dis. 2012. 18:38–47.

4. Guiso N, Wirsing von König CH, Forsyth K, Tan T, Plotkin SA. The global pertussis initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010. Vaccine. 2011. 29:1115–1121.

5. Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J. 2003. 22:628–634.

6. Bechini A, Tiscione E, Boccalini S, Levi M, Bonanni P. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations. Vaccine. 2012. 30:5179–5190.

7. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011. 60:1424–1426.

8. Cheong HJ. Vaccination for adult. 2012. 2nd ed. Seoul: MIP;133–151.

9. Choe YJ, Park YJ, Jung C, Bae GR, Lee DH. National pertussis surveillance in South Korea 1955-2011: epidemiological and clinical trends. Int J Infect Dis. 2012. 16:e850–e854.

10. Fisher BM, Scott J, Hart J, Winn VD, Gibbs RS, Lynch AM. Behaviors and perceptions regarding seasonal and H1N1 influenza vaccination during pregnancy. Am J Obstet Gynecol. 2011. 204:6 Suppl 1. S107–S111.

11. Goldfarb I, Panda B, Wylie B, Riley L. Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic. Am J Obstet Gynecol. 2011. 204:6 Suppl 1. S112–S115.

12. Naleway AL, Smith WJ, Mullooly JP. Delivering influenza vaccine to pregnant women. Epidemiol Rev. 2006. 28:47–53.

13. Kim MJ, Lee SY, Lee KS, Kim A, Son D, Chung MH, Park SG, Park JH, Lee BI, Lee JS. Influenza vaccine coverage rate and related factors on pregnant women. Infect Chemother. 2009. 41:349–354.

14. Shakib JH, Wyman L, Gesteland PH, Staes CJ, Bennion DW, Byington CL. Should the pertussis case definition for public health reporting be refined? J Public Health Manag Pract. 2009. 15:479–484.

15. Centers for Disease Control and Prevention (CDC). Pertussis epidemic--Washington, 2012. MMWR Morb Mortal Wkly Rep. 2012. 61:517–522.

16. Castagnini LA, Healy CM, Rench MA, Wootton SH, Munoz FM, Baker CJ. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis. 2012. 54:78–84.

17. Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol. 2011. 204:334.e1–334.e5.

18. Leuridan E, Hens N, Peeters N, de Witte L, Van der Meeren O, Van Damme P. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J. 2011. 30:608–610.

19. Mooi FR, de Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect Dis. 2007. 7:614–624.

20. Knuf M, Schmitt HJ, Jacquet JM, Collard A, Kieninger D, Meyer CU, Siegrist CA, Zepp F. Booster vaccination after neonatal priming with acellular pertussis vaccine. J Pediatr. 2010. 156:675–678.

21. Knuf M, Schmitt HJ, Wolter J, Schuerman L, Jacquet JM, Kieninger D, Siegrist CA, Zepp F. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr. 2008. 152:655–660. 660.e1

22. Wood N, McIntyre P, Marshall H, Roberton D. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J. 2010. 29:209–215.

23. Cheng PJ, Huang SY, Shaw SW, Kao CC, Chueh HY, Chang SD, Hsu TY, Kung FT, Hsieh TT. Factors influencing women's decisions regarding pertussis vaccine: A decision-making study in the Postpartum Pertussis Immunization Program of a teaching hospital in Taiwan. Vaccine. 2010. 28:5641–5647.